title: Medical therapies for meningiomas.
abstract: Meningiomas are the most common primary brain tumor in adults. Although the majority of these tumors can be effectively treated with surgery and radiation therapy, an important subset of patients have inoperable tumors, or develop recurrent disease after surgery and radiotherapy, and require some form of medical therapy. There are increasing numbers of studies evaluating various medical therapies but the results remain disappointing. Chemotherapies and hormonal therapies have been generally ineffective, although somatostatin analogues may have therapeutic potential. There is also increasing interest in targeted molecular therapies. Agents inhibiting platelet derived growth factor receptors and epidermal growth factor receptors have shown little efficacy, but molecular agents inhibiting vascular endothelial growth factor receptors appear to have some promise. As with other tumors, advances in the medical therapies for meningiomas will require improved understanding of the molecular pathogenesis of these tumors, more predictive preclinical models, and efficient mechanisms for conducting clinical trials, given the small population of eligible patients.
authors.affiliation: Center for Neuro-Oncology, Department of Medical Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA 02115, USA. pwen@partners.org
authors.forename: Patrick Y
authors.initials: PY
authors.lastname: Wen
authors.forename: Eudocia
authors.initials: E
authors.lastname: Quant
authors.forename: Jan
authors.initials: J
authors.lastname: Drappatz
authors.forename: Rameen
authors.initials: R
authors.lastname: Beroukhim
authors.forename: Andrew D
authors.initials: AD
authors.lastname: Norden
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D016371:Cranial Irradiation; D006801:Humans; D008577:Meningeal Neoplasms / Q000628:therapy*; D008579:Meningioma / Q000628:therapy*; D016634:Radiosurgery
chemical_list: D000970:Antineoplastic Agents
references.citation: Cancer Cell. 2002 Sep;2(3):183-92
references.pmid: 12242151
references.citation: J Clin Oncol. 2005 Apr 1;23(10):2411-22
references.pmid: 15800333
references.citation: Nat Rev Cancer. 2005 Jul;5(7):505-15
references.pmid: 16069815
references.citation: Neurosurgery. 1997 Jun;40(6):1269-77
references.pmid: 9179901
references.citation: Clin Cancer Res. 2001 Aug;7(8):2269-76
references.pmid: 11489801
references.citation: Int J Oncol. 2006 Jul;29(1):25-32
references.pmid: 16773181
references.citation: J Neurooncol. 2002 Mar;57(1):19-26
references.pmid: 12125963
references.citation: Curr Neurol Neurosci Rep. 2009 May;9(3):231-40
references.pmid: 19348712
references.citation: Nature. 2005 Jun 2;435(7042):677-81
references.pmid: 15902208
references.citation: J Clin Oncol. 2009 Oct 1;27(28):4733-40
references.pmid: 19720927
references.citation: Br J Neurosurg. 2004 Oct;18(5):495-9
references.pmid: 15799152
references.citation: J Neuropathol Exp Neurol. 2005 Dec;64(12):1029-36
references.pmid: 16319713
references.citation: J Neurosurg. 2008 Feb;108(2):304-10
references.pmid: 18240927
references.citation: Neurosurgery. 1997 May;40(5):1016-26
references.pmid: 9149260
references.citation: J Cardiovasc Pharmacol. 2000 Nov;36(5 Suppl 1):S135-9
references.pmid: 11078359
references.citation: Cancer Res. 1997 Jul 1;57(13):2611-4
references.pmid: 9205065
references.citation: Expert Rev Anticancer Ther. 2005 Apr;5(2):355-78
references.pmid: 15877531
references.citation: J Neurooncol. 1996 Sep;29(3):207-16
references.pmid: 8858526
references.citation: J Neurosurg. 2001 Mar;94(3):487-92
references.pmid: 11235955
references.citation: Cancer Control. 2003 Mar-Apr;10(2):148-58
references.pmid: 12712009
references.citation: J Neurooncol. 2008 Jan;86(1):109-22
references.pmid: 17624496
references.citation: Neurosurgery. 2007 Apr;60(4):750-9; discussion 759-60
references.pmid: 17415213
references.citation: Cancer Cell. 2004 Dec;6(6):553-63
references.pmid: 15607960
references.citation: Nat Rev Cancer. 2009 Aug;9(8):550-62
references.pmid: 19629070
references.citation: Neuropathol Appl Neurobiol. 1998 Dec;24(6):441-52
references.pmid: 9888154
references.citation: J Neurooncol. 1997 Dec;35(3):289-301
references.pmid: 9440026
references.citation: Front Biosci (Elite Ed). 2009 Jun 01;1:494-500
references.pmid: 19482663
references.citation: J Neurosurg. 1999 Sep;91(3):440-6
references.pmid: 10470819
references.citation: CA Cancer J Clin. 2010 Jul-Aug;60(4):222-43
references.pmid: 20554717
references.citation: Curr Treat Options Oncol. 2004 Dec;5(6):499-509
references.pmid: 15509483
references.citation: Cancer Chemother Biol Response Modif. 2005;22:123-33
references.pmid: 16110610
references.citation: Crit Rev Oncol Hematol. 2008 Aug;67(2):153-71
references.pmid: 18342535
references.citation: Genes Dev. 2002 May 1;16(9):1060-5
references.pmid: 12000789
references.citation: Neurosurgery. 2007 May;60(5):787-98; discussion 787-98
references.pmid: 17460514
references.citation: Expert Rev Anticancer Ther. 2006 May;6(5):679-95
references.pmid: 16759160
references.citation: J Neurooncol. 2004 Jan;66(1-2):155-66
references.pmid: 15015781
references.citation: Cancer Genet Cytogenet. 2008 Nov;187(1):25-7
references.pmid: 18992637
references.citation: J Nucl Med. 1998 Nov;39(11):1913-7
references.pmid: 9829583
references.citation: J Neurosurg. 1997 Aug;87(2):315-23
references.pmid: 9254099
references.citation: J Neuropathol Exp Neurol. 2004 Apr;63(4):275-86
references.pmid: 15099018
references.citation: Cancer Treat Rev. 2006 May;32(3):157-65
references.pmid: 16516391
references.citation: J Clin Oncol. 2010 Feb 20;28(6):1075-83
references.pmid: 20085938
references.citation: Expert Rev Mol Diagn. 2006 Jul;6(4):613-26
references.pmid: 16824034
references.citation: Cancer. 2008 Oct 15;113(8):2146-51
references.pmid: 18756531
references.citation: J Neurooncol. 2004 Jan;66(1-2):9-16
references.pmid: 15015765
references.citation: Nat Rev Cancer. 2005 Apr;5(4):297-309
references.pmid: 15803156
references.citation: Cancer. 1990 Jul 1;66(1):152-5
references.pmid: 2354402
references.citation: Neurosurg Focus. 2007;23(4):E11
references.pmid: 17961035
references.citation: Expert Opin Investig Drugs. 2008 Aug;17(8):1225-35
references.pmid: 18616418
references.citation: J Neurooncol. 2004 Mar-Apr;67(1-2):221-6
references.pmid: 15072471
references.citation: Neurology. 1975 Aug;25(8):705-12
references.pmid: 1171403
references.citation: Neurosurg Focus. 2007;23(4):E10
references.pmid: 17961034
references.citation: J Neurooncol. 2014 Mar;117(1):93-101
references.pmid: 24449400
references.citation: Int J Oncol. 2003 Feb;22(2):289-94
references.pmid: 12527924
references.citation: J Neurosurg. 1996 May;84(5):733-6
references.pmid: 8622144
references.citation: Brain Pathol. 2008 Apr;18(2):172-9
references.pmid: 18093250
references.citation: J Neurosurg. 2000 Feb;92(2):306-14
references.pmid: 10659019
references.citation: Brain Pathol. 2008 Jan;18(1):62-70
references.pmid: 17924978
references.citation: J Neurosurg. 1997 May;86(5):845-52
references.pmid: 9126901
references.citation: Lancet Neurol. 2006 Dec;5(12):1045-54
references.pmid: 17110285
references.citation: Neurosurg Focus. 2007;23(4):E9
references.pmid: 17961046
references.citation: J Neurooncol. 2004 Nov;70(2):183-202
references.pmid: 15674477
references.citation: Neurology. 2004 Apr 13;62(7):1210-2
references.pmid: 15079029
references.citation: J Neurosurg. 2007 Mar;106(3):455-62
references.pmid: 17367069
references.citation: Hum Reprod. 1994 Jun;9 Suppl 1:202-7
references.pmid: 7962466
references.citation: Surg Gynecol Obstet. 1993 Nov;177(5):488-96
references.pmid: 8211601
references.citation: Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2663-70
references.pmid: 18843008
references.citation: J Neurosurg. 2002 Sep;97(3):668-75
references.pmid: 12296652
references.citation: Cancer Lett. 2004 Sep 15;213(1):117-24
references.pmid: 15312691
references.citation: Am J Clin Oncol. 2009 Feb;32(1):73-85
references.pmid: 19194129
references.citation: Nat Rev Cancer. 2003 Jul;3(7):489-501
references.pmid: 12835669
references.citation: Neurosurgery. 2000 Nov;47(5):1185-95
references.pmid: 11063113
references.citation: Acta Neuropathol. 2004 Aug;108(2):135-42
references.pmid: 15148612
references.citation: J Clin Oncol. 2005 Dec 20;23(36):9394-407
references.pmid: 16361639
references.citation: J Clin Oncol. 2008 Jan 10;26(2):279-82
references.pmid: 18182668
references.citation: J Neurooncol. 1993 Jan;15(1):75-7
references.pmid: 8455065
references.citation: Neurosurgery. 2005 Sep;57(3):538-50; discussion 538-50
references.pmid: 16145534
references.citation: Int J Cancer. 2005 Dec 20;117(6):996-1001
references.pmid: 15986431
references.citation: J Neurosurg. 2007 Jun;106(6):1034-40
references.pmid: 17564176
references.citation: Int J Cancer. 1990 Nov 15;46(5):772-8
references.pmid: 1699901
references.citation: J Clin Neurosci. 2001 May;8 Suppl 1:49-53
references.pmid: 11386826
references.citation: Surg Neurol. 1985 Sep;24(3):245-9
references.pmid: 4023903
references.citation: Eur J Endocrinol. 2002 May;146(5):707-16
references.pmid: 11980628
references.citation: J Neurooncol. 1996 Sep;29(3):269-72
references.pmid: 8858533
references.citation: Int J Cancer. 1990 Jul 15;46(1):16-21
references.pmid: 2163990
references.citation: Endocr Relat Cancer. 2008 Dec;15(4):931-41
references.pmid: 18632875
references.citation: Oncogene. 2008 Oct 20;27(48):6252-75
references.pmid: 18931692
references.citation: Cancer Treat Rev. 2006 Oct;32(6):407-16
references.pmid: 16889900
references.citation: Cancer Invest. 2006 Dec;24(8):727-33
references.pmid: 17162554
references.citation: J Clin Oncol. 2007 Sep 10;25(26):4033-42
references.pmid: 17827451
references.citation: Neuroimaging Clin N Am. 2010 Aug;20(3):425-48
references.pmid: 20708556
references.citation: J Neurol Neurosurg Psychiatry. 1992 Jun;55(6):486-90
references.pmid: 1619417
references.citation: CA Cancer J Clin. 2005 May-Jun;55(3):178-94
references.pmid: 15890640
references.citation: J Nucl Med. 2005 May;46(5):763-9
references.pmid: 15872348
references.citation: J Neurosurg. 1998 May;88(5):938-9
references.pmid: 9576275
references.citation: Nat Rev Cancer. 2008 Oct;8(10):782-98
references.pmid: 18813321
references.citation: J Neurosurg. 1997 Jan;86(1):113-20
references.pmid: 8988089
references.citation: Lancet. 2004 May 8;363(9420):1535-43
references.pmid: 15135603
references.citation: Expert Opin Ther Targets. 2007 Jan;11(1):91-100
references.pmid: 17150037
references.citation: Expert Rev Neurother. 2006 Oct;6(10):1447-64
references.pmid: 17078786
references.citation: Expert Rev Anticancer Ther. 2005 Apr;5(2):333-42
references.pmid: 15877529
references.citation: J Pathol. 1999 Sep;189(1):66-71
references.pmid: 10451490
references.citation: Nat Rev Cancer. 2008 Feb;8(2):121-32
references.pmid: 18202696
references.citation: Hum Pathol. 1994 Feb;25(2):146-53
references.pmid: 8119714
references.citation: J Neurosurg. 2001 Nov;95(5):839-44
references.pmid: 11702875
references.citation: Clin Cancer Res. 2005 Jun 1;11(11):4074-82
references.pmid: 15930342
references.citation: J Neurosurg. 2001 Feb;94(2):293-300
references.pmid: 11213968
references.citation: Cancer Res. 2005 Feb 15;65(4):1547-53
references.pmid: 15735044
references.citation: J Neurosurg Sci. 1993 Dec;37(4):237-41
references.pmid: 7931648
references.citation: J Neurooncol. 2006 Jul;78(3):271-6
references.pmid: 16628476
references.citation: Acta Neurochir (Wien). 2000;142(5):493-505
references.pmid: 10898356
references.citation: J Neurooncol. 2010 Jan;96(2):211-7
references.pmid: 19562255
references.citation: Cancer Biol Ther. 2004 Mar;3(3):247-50
references.pmid: 15107611
references.citation: Cancer. 2007 Aug 1;110(3):471-6
references.pmid: 17580362
references.citation: Neurosurgery. 1998 Oct;43(4):890-8; discussion 898-9
references.pmid: 9766317
references.citation: J Neurooncol. 1995;23(1):23-9
references.pmid: 7542695
references.citation: BMC Cancer. 2006 Jun 07;6:152
references.pmid: 16759391
references.citation: Curr Drug Targets. 2010 Mar;11(3):291-302
references.pmid: 20210754
references.citation: J Neurosurg. 1997 May;86(5):840-4
references.pmid: 9126900
references.citation: Neuro Oncol. 2009 Dec;11(6):853-60
references.pmid: 19293394
references.citation: Int J Oncol. 2008 Nov;33(5):937-47
references.pmid: 18949356
references.citation: J Clin Neurosci. 2002 Mar;9(2):156-8
references.pmid: 11922703
references.citation: J Clin Oncol. 2006 Apr 10;24(11):1770-83
references.pmid: 16603719
references.citation: Skull Base. 2008 May;18(3):173-87
references.pmid: 18978964
references.citation: Neurosurg Rev. 2004 Oct;27(4):238-45
references.pmid: 15168138
references.citation: N Engl J Med. 2008 May 8;358(19):2039-49
references.pmid: 18463380
references.citation: Curr Treat Options Neurol. 2004 Jul;6(4):297-305
references.pmid: 15157407
references.citation: Oncology (Williston Park). 2004 Nov;18(13 Suppl 10):5-10
references.pmid: 15651171
references.citation: Brain Tumor Pathol. 2001;18(1):1-5
references.pmid: 11517968
references.citation: J Clin Invest. 1995 Oct;96(4):2017-25
references.pmid: 7560095
references.citation: J Neurooncol. 1995 Oct;26(1):45-51
references.pmid: 8583244
references.citation: Acta Oncol. 2010 Aug;49(6):872-4
references.pmid: 20429732
references.citation: Neurosurgery. 2000 Apr;46(4):938-47; discussion 947-8
references.pmid: 10764269
references.citation: J Neurosurg. 2002 Aug;97(2):341-6
references.pmid: 12186462
references.citation: J Neurosurg. 1991 Jun;74(6):861-6
references.pmid: 2033444
references.citation: J Neurosurg. 1996 May;84(5):852-8; discussion 858-9
references.pmid: 8622161
references.citation: Neurosurg Clin N Am. 2006 Apr;17(2):111-20, vi
references.pmid: 16793503
references.citation: N Engl J Med. 2007 Dec 6;357(23):2411-2
references.pmid: 18057351
references.citation: Eur J Endocrinol. 2005 Jan;152(1):161-2
references.pmid: 15762200
references.citation: Ann Oncol. 2001;12 Suppl 2:S131-4
references.pmid: 11762340
references.citation: Expert Rev Neurother. 2004 Jul;4(4):641-8
references.pmid: 15853583
references.citation: J Neurooncol. 2009 Mar;92(1):1-6
references.pmid: 19023520
references.citation: Cell Mol Life Sci. 2007 Feb;64(4):458-78
references.pmid: 17260089
references.citation: Eur J Cancer. 1991;27(4):416-9
references.pmid: 1828169
references.citation: Cancer Res. 1987 Apr 15;47(8):2172-6
references.pmid: 3493842
references.citation: Neurology. 2007 Sep 4;69(10):969-73
references.pmid: 17785665
references.citation: Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3749-55
references.pmid: 14506167
references.citation: Hybridoma. 2001 Apr;20(2):131-6
references.pmid: 11394532
references.citation: Neurosurgery. 1997 Feb;40(2):271-5
references.pmid: 9007858
references.citation: Neurology. 2004 Sep 28;63(6):1133-4
references.pmid: 15452322